Bio-Me AS
PrivateLast Round
Grant
Jun 28, 2021
Total Funding Raised
$2.6M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Bio-Me AS operates in Healthcare & Life Sciences and is based in Oslo. Its latest recorded funding round was a Grant round in June 2021.
Bio-Me AS is a biotechnology company that provides Precision Microbiome Profiling (PMP™) services and develops microbiome-based molecular diagnostics with a focus on women's health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bio-Me AS Comparables
Compare Bio-Me AS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genetic Analysis AS | 82% | |
| SeqBiome Ltd | 78% | |
| Cmbio | 77% |
For institutional investors. Book with your work email.
Bio-Me AS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 28, 2021 | ||||
| VC Round | Jun 10, 2021 | ||||
| Grant | Apr 23, 2020 | ||||
| Pre Seed | Nov 20, 2018 | ||||
| Accelerator | Aug 28, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Bio-Me AS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Katapult Ocean | Accelerator |
| The Research Council of Norway | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 23, 2026
Grew 27% QoQ, from 15 to 19 employees.
- Aug 22, 2026
Monthly visitors grew 89% MoM, reaching 6K.
For institutional investors. Book with your work email.
Bio-Me AS Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bio-Me AS's valuation, stock price, and market status.
Is Bio-Me AS a public or private company?
Bio-Me AS is a private company.
What is the current stock price of Bio-Me AS?
Bio-Me AS is a private company, so its shares have no public market price. Caplight tracks Bio-Me AS's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bio-Me AS worth (valuation)?
Valuation information for Bio-Me AS is not publicly available.
Can I buy Bio-Me AS stock?
Bio-Me AS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bio-Me AS's last funding round?
Bio-Me AS's most recent funding round was Grant on June 28, 2021.
Who are the main investors in Bio-Me AS?
Key investors in Bio-Me AS include Katapult Ocean, The Research Council of Norway.
Will Bio-Me AS IPO soon?
No public IPO plans have been announced for Bio-Me AS.
How can I track Bio-Me AS secondary market activity?
Caplight tracks bids, offers, and trades in Bio-Me AS's shares on secondary markets.